The Prometheus League
Breaking News and Updates
- Abolition Of Work
- Ai
- Alt-right
- Alternative Medicine
- Antifa
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Ascension
- Astronomy
- Atheism
- Atheist
- Atlas Shrugged
- Automation
- Ayn Rand
- Bahamas
- Bankruptcy
- Basic Income Guarantee
- Big Tech
- Bitcoin
- Black Lives Matter
- Blackjack
- Boca Chica Texas
- Brexit
- Caribbean
- Casino
- Casino Affiliate
- Cbd Oil
- Censorship
- Cf
- Chess Engines
- Childfree
- Cloning
- Cloud Computing
- Conscious Evolution
- Corona Virus
- Cosmic Heaven
- Covid-19
- Cryonics
- Cryptocurrency
- Cyberpunk
- Darwinism
- Democrat
- Designer Babies
- DNA
- Donald Trump
- Eczema
- Elon Musk
- Entheogens
- Ethical Egoism
- Eugenic Concepts
- Eugenics
- Euthanasia
- Evolution
- Extropian
- Extropianism
- Extropy
- Fake News
- Federalism
- Federalist
- Fifth Amendment
- Fifth Amendment
- Financial Independence
- First Amendment
- Fiscal Freedom
- Food Supplements
- Fourth Amendment
- Fourth Amendment
- Free Speech
- Freedom
- Freedom of Speech
- Futurism
- Futurist
- Gambling
- Gene Medicine
- Genetic Engineering
- Genome
- Germ Warfare
- Golden Rule
- Government Oppression
- Hedonism
- High Seas
- History
- Hubble Telescope
- Human Genetic Engineering
- Human Genetics
- Human Immortality
- Human Longevity
- Illuminati
- Immortality
- Immortality Medicine
- Intentional Communities
- Jacinda Ardern
- Jitsi
- Jordan Peterson
- Las Vegas
- Liberal
- Libertarian
- Libertarianism
- Liberty
- Life Extension
- Macau
- Marie Byrd Land
- Mars
- Mars Colonization
- Mars Colony
- Memetics
- Micronations
- Mind Uploading
- Minerva Reefs
- Modern Satanism
- Moon Colonization
- Nanotech
- National Vanguard
- NATO
- Neo-eugenics
- Neurohacking
- Neurotechnology
- New Utopia
- New Zealand
- Nihilism
- Nootropics
- NSA
- Oceania
- Offshore
- Olympics
- Online Casino
- Online Gambling
- Pantheism
- Personal Empowerment
- Poker
- Political Correctness
- Politically Incorrect
- Polygamy
- Populism
- Post Human
- Post Humanism
- Posthuman
- Posthumanism
- Private Islands
- Progress
- Proud Boys
- Psoriasis
- Psychedelics
- Putin
- Quantum Computing
- Quantum Physics
- Rationalism
- Republican
- Resource Based Economy
- Robotics
- Rockall
- Ron Paul
- Roulette
- Russia
- Sealand
- Seasteading
- Second Amendment
- Second Amendment
- Seychelles
- Singularitarianism
- Singularity
- Socio-economic Collapse
- Space Exploration
- Space Station
- Space Travel
- Spacex
- Sports Betting
- Sportsbook
- Superintelligence
- Survivalism
- Talmud
- Technology
- Teilhard De Charden
- Terraforming Mars
- The Singularity
- Tms
- Tor Browser
- Trance
- Transhuman
- Transhuman News
- Transhumanism
- Transhumanist
- Transtopian
- Transtopianism
- Ukraine
- Uncategorized
- Vaping
- Victimless Crimes
- Virtual Reality
- Wage Slavery
- War On Drugs
- Waveland
- Ww3
- Yahoo
- Zeitgeist Movement
-
Prometheism
-
Forbidden Fruit
-
The Evolutionary Perspective
Category Archives: Transhuman News
Federal Funding Cuts Put Missing Persons and John Doe Cases on the Back Burner – TIME
Posted: August 20, 2017 at 5:50 pm
Hero Images Inc.?2015 Hero Images Inc. All rights reserved.
(DALLAS) Karen Stipes always believed her missing mother was "Mountain Jane Doe," buried unidentified in a paupers' cemetery deep in the woods outside Harlan, Kentucky. But without proof, it took nearly half a century and the development of DNA technology for forensic scientists at the University of North Texas to confirm her intuition.
Police didn't know who Sonja Kaye Blair-Adams was when a man picking flowers on a trail found her body stabbed multiple times in 1969. It remained a mystery to the locals until advances in forensic science prompted renewed efforts to identify the body and resume the hunt for her killer. While police have yet to solve the killing, Stipes said the restoration of her mother's identity has provided at least some closure.
But now the same Texas lab that handled Blair-Adams' DNA has had to stop testing samples like hers that come from outside the state due to a lack of funding, meaning family members of missing and unidentified people are waiting longer for their cases to be solved.
"Everyone deserves to have their unidentified found," Stipes said. "I feel my mother was disrespected being unidentified for so long. There wasn't DNA testing in 1969 when my mother died, but it's 2017. I think it has gotten overlooked."
For years, law enforcement looking for a breakthrough in a cold case could count on sending samples of unknown bodies to the Center for Human Identification at the University of North Texas. The lab is a world leader in mitochondrial DNA testing from decomposing and partial remains and provided testing for missing and unidentified people at no cost to investigators.
But this year the National Institute of Justice decided not to offer millions of dollars in grants for DNA technology to identify missing people and instead reallocated that money to programs that help state and local governments audit and track backlogged rape kits. The U.S. agency also introduced new grants to help medical examiners and coroner's offices meet accreditation standards and recruit forensic pathologists.
Agency officials said the university will receive supplemental funding in the next fiscal year, which starts Oct. 1, but the drop in casework has brought new attention to the lab's value and the importance of DNA in solving missing persons cases.
"There was a lot of public tension," said Todd Matthews, a spokesman for the National Missing and Unidentified Persons System at the university. "These are precious resources, and we can't take for granted something we don't know will continue."
The lab's funding situation isn't unique. The National Institute of Justice is the only federal agency that provides grants for labs analyzing DNA to identify the missing. Without those resources, investigators are left with fewer options for critical testing. Detectives have had to bust their budgets on expensive testing at private labs or submit remains to lengthy queues at local FBI labs. Others have stored their samples and suspended investigations until testing can resume.
"I've been sending letters and making phone calls to the NIJ on UNT's behalf. This is an absolute priority," said Sgt. Jason Moran, a detective with the Cook County, Illinois, sheriff's office. "It's hard to work if you don't know the identity of the victim."
Investigators say the university has become a crucial resource in the work to identify the 100,000 missing persons and 40,000 sets of unidentified remains across the United States. Over the past two decades, the lab has identified victims of 9/11 and Hurricane Katrina. Last year, the lab received up to 4,000 out-of-state samples, which comprised half of all DNA testing in the country, lab director Bruce Budowle said.
But the U.S. also has a huge backlog of untested rape kits. The national nonprofit End the Backlog estimates that there are more than 185,000 in the 38 states for which data is available. Reducing that number has drawn approximately $131 million in federal funding for the Sexual Assault Kit Initiative.
"We had to make a tough decision to fund other programs," said Gerry LaPorte, director of the Office of Investigative and Forensic Sciences at the National Institute of Justice. "It was very difficult because there are so many needs in the community."
Even without the influx of funding, the University of North Texas has continued to work cases, including testing of the state's backlogged rape kits. The lab has also had success reducing its own backlog. Last month, it helped the Cook County sheriff's office solve a 40-year mystery by identifying a victim of Chicago serial killer John Wayne Gacy.
"If we keep doing quality work, people will want us to be around," Budowle said. "This is a national lab, and that's a good investment. We're optimistic at this point that everything will be addressed. Hopefully sooner rather than later."
More:
Federal Funding Cuts Put Missing Persons and John Doe Cases on the Back Burner - TIME
Posted in DNA
Comments Off on Federal Funding Cuts Put Missing Persons and John Doe Cases on the Back Burner – TIME
Birding: DNA technology gives us new insights into taxonomy – Press Herald
Posted: at 5:50 pm
Humans have a penchant for organizing. We like order. This need for organization certainly drove Carl Linnaeus, a Swedish naturalist, to publish the first catalog of life, the Systema Naturae, in 1735. He devised the framework we still use in our taxonomy.
In the last column, we explored the challenges of recognizing species. New knowledge forces us to re-examine our understanding of species variation. We regularly gain or lose species on our life lists as former species are divided into two or more new species or others combined into a single species.
Taxonomists do have methods for defining a species. The problem is that there is more than one method, and the different approaches do not always get to the same conclusion.
Similar species are placed in a genus. Genera (the plural of genus) that are similar are placed in the same family. And on we go upward to order, then class, then phylum, then kingdom. Thus, the tree of life is organized.
Linnaeus based his taxonomy on similarity of form. In the next century, Charles Darwin saw that Linnaeus system could reflect relatedness. Species in the same genus had a more recent ancestor than two species in different genera or families. He said that our classification of life should be a genealogy.
But how does one decide how large a genus or order should be? Surprisingly, the answer is that it is arbitrary, depending on the preferences of the taxonomist. Some genera have a single species, like the genus Icteria, containing only the yellow-breasted chat. On the other hand, the snail genus Conus contains 750 species, and the sedge genus Carex has nearly 1,800 species.
Ultimately, the size of the genus or other taxonomic group is not important as long as it can be defended as a natural grouping. Any taxonomic group should be monophyletic (one branch), containing species more closely related to each other than to any species in other groups. Darwins desire to have our taxonomy be a genealogy is really a desire for our classifications to contain only monophyletic groups.
The job of erecting and revising a taxonomic system for any group of organisms had to rely on similarity of structure until the turn of the 21st century. Now, our ability to rapidly sequence and compare the DNA of organisms gives us a second powerful way to assess relatedness.
Some genes change through mutations quite rapidly, so DNA comparisons of these genes are useful for exploring closely related, recently separated species. Other genes mutate very slowly, so they can be used to assess the relationship between distant groups like phyla or classes. Some genes change at intermediate rates, so they can be used to assess the relatedness of orders and families.
DNA comparisons have shaken the foundation of our bird taxonomy. Such comparisons allow us to avoid the twin pitfalls of species from a common ancestor diverging strongly and species in different groups converging to similar shapes.
The grebe order was formerly placed close to the loon order. DNA comparisons now tell us that the closest relatives of grebes are flamingoes! Here we have a case where species have strongly diverged from their common ancestor. Another cool example is that the flightless penguins are most closely related to the albatrosses and shearwaters, masters of long-distant flight.
On the other hand, the hawks and falcons were formerly lumped into the same order. DNA tells us that convergence to high-speed, sharp-taloned predators has occurred. The two types of raptors are placed in different orders now. The closest relatives of the falcons are the parrots and perching birds. New World vultures share a common ancestor with hawks.
Look for these changes and more to be reflected in new editions of field guides.
Herb Wilson teaches ornithology and other biology courses at Colby College. He welcomes reader comments and questions at
[emailprotected]
Read more here:
Birding: DNA technology gives us new insights into taxonomy - Press Herald
Posted in DNA
Comments Off on Birding: DNA technology gives us new insights into taxonomy – Press Herald
Scientists Try Gene Editing In Human Embryos : Shots – Health … – NPR
Posted: at 5:50 pm
This sequence of images shows the development of embryos formed after eggs were injected with both CRISPR, a gene-editing tool, and sperm from a donor with a genetic mutation known to cause cardiomyopathy. OHSU hide caption
This sequence of images shows the development of embryos formed after eggs were injected with both CRISPR, a gene-editing tool, and sperm from a donor with a genetic mutation known to cause cardiomyopathy.
From the thirteenth floor of a glass tower at the Oregon Health & Science University, you get a panoramic view of downtown Portland and the majestic mountains in the distance. But it's what's happening inside the building that's brought me here.
"Should we go do this thing?" lab manager Amy Koski asks.
She's just gotten a call from the fertility clinic three floors down. A woman undergoing in vitro fertilization has had her eggs extracted. One of the eggs is too immature to be used to try to create a baby, so she's donating it to research.
Koski grabs a small metal box and rushes to the elevator. It's her portable incubator.
"You want to keep the eggs very happy and warm," she says. "When you're jostling them and moving them, they get a little unhappy."
Human eggs are the key starting point for the groundbreaking experiments underway in this lab. It's run by Shoukhrat Mitalipov, a biologist who's been on the cutting edge of embryonic genetic research for decades.
Mitalipov and his international team electrified the world this summer when the group announced it had successfully and seemingly safely figured out how to efficiently edit the DNA in human embryos.
For the first time, they said, they had corrected a mutation that causes a potentially fatal heart condition. The hope is this landmark step could someday help prevent thousands of genetic diseases that have plagued families for generations.
Critics, however, pounced on the news. They fear editing DNA in human embryos is unsafe, unnecessary and could open the door to "designer babies" and possibly someday to genetically enhanced people who are considered superior by society.
As the debate raged last week, I asked Mitalipov if I could visit his lab to see the next round of his experiments. He wants to confirm his initial results and determine whether the method can be used to repair other mutations.
He agreed to a visit, and on Monday, I became the first journalist to see these scientists cross a line that, until recently, had been taboo.
A small room for big science
I've followed Mitalipov's research for years and have visited the labs of other scientists doing related work in Stockholm, London and elsewhere.
Still, I stepped into Mitalipov's embryology lab unsure of exactly what I was about to see and eager to better understand what allowed these scientists to succeed where others had failed.
"This is our small room, but that's where usually lots of big science happened," says Mitalipov, who was born in the former Soviet Union. "We believe this room is really magic in terms of science."
Shoukhrat Mitalipov points to an image of an edited embryo inside an incubator at the Center for Embryonic Cell and Gene Therapy in Portland, Ore. Rob Stein/NPR hide caption
Shoukhrat Mitalipov points to an image of an edited embryo inside an incubator at the Center for Embryonic Cell and Gene Therapy in Portland, Ore.
He points to a microscope where his colleague, Nuria Marti-Gutierrez, has just positioned a Petri dish. I'm able to watch everything she's doing on a computer screen.
Mitalipov points to a round silvery blob. It's the egg. "You can see it moving," he says.
Suddenly, a bunch of tiny ovals flit across the screen. They are sperm from a donor who has a genetic mutation that causes cardiomyopathy, a potentially fatal heart condition.
Marti-Gutierrez draws the sperm into a thin glass rod called a pipette. She then adds a microscopic gene-editing tool a combination of chemical sequences known as CRISPR that can make very precise changes in DNA.
In this case, CRISPR will zero in on the cardiomyopathy mutation to literally slice the defect in the DNA.
Finally, she pierces the shell of the egg with the pipette and injects the sperm and CRISPR. Almost before I know it's happening, it's done. A human embryo has been created and edited before my eyes.
"That's it?" I ask.
"Yep," Mitalipov says, chuckling to himself.
It was amazingly fast and seemingly easy you could imagine a future where this sort of thing might become routine.
"This is how we do it," Mitalipov says matter-of-factly. He refers to the process as "DNA surgery."
Mitalipov and his team immediately do a second edit and then transfer the embryos to a larger incubator. The scientists will then spend the next few days monitoring live video of the two embryos, along with 17 others they had edited the weekend before, to see how they develop.
What's at work
Mitalipov thinks his team accomplished this feat by injecting the mutant sperm and the DNA editor into the egg at the same time. Previous attempts to edit DNA in human embryos were far less accurate and produced dangerous mutations elsewhere in the embryos' DNA.
Mitalipov and his colleagues are not sure exactly how it works. But they think that when CRISPR cuts the defective gene, the slice triggers the embryo to repair itself.
If future experiments confirm the results and show that the technique also works for other mutations, Mitalipov thinks the process could wipe out many diseases that have plagued families for generations, though he cautions that any practical application is still easily a decade or more away.
"[There are] about 10,000 different mutations causing so many different conditions and diseases," he says, pointing to Huntington's disease, cystic fibrosis and even possibly inherited forms of Alzheimer's and breast cancer.
"We're talking about millions of people affected. So I think the implications are huge," he says.
"I think this is a significant advance," says George Church, a Harvard geneticist. "This is important not only for parents who want to have healthy children, but more generally, it opens the door to preventative medicine where we can avoid a lot of painful genetic problems."
Skepticism, criticism and an ethical debate
While the results seem promising so far, there are still many questions. Some scientists remain skeptical that Mitalipov has really done what he says he's done.
"Unfortunately, the data do not allow the conclusion of correction for the embryos," says Dieter Egli, a biologist at Columbia University. "There are a number of other outcomes that are much more likely."
Mitalipov acknowledges that his work still needs to be reproduced by others, but he is confident his method is working.
Others are worried that less careful scientists might rush ahead too quickly and attempt to make babies before the technique has been proven to work and be safe.
"This is a strong statement that we can do genome editing," says George Daley, dean of the Harvard Medical School. "The question that remains is, 'Should we?' "
"I think it would be professionally irresponsible for any clinician to use this technology to make a baby," Daley adds. "It's just simply too early. It would be premature."
The idea of changing human DNA in ways that could be passed down for generations has long been considered off-limits. The fear is scientists could make mistakes and create new diseases that would persist for generations.
Some critics go so far as to say that scientists are essentially playing God by taking this step. They fear it will lead to parents picking and choosing the traits of their children. While that is not yet technically possible, critics say scientists are moving quickly toward that possibility.
"I think it's extraordinarily disturbing," says Marcy Darnovsky, who heads the Center for Genetics and Society, a watchdog group. "We'll see fertility clinics advertising gene editing for enhancement purposes. We'll see children being born who are said to biologically superior."
Mitalipov and his colleagues acknowledge the fears and agree the technique should be carefully regulated and only used for medical purposes. But, they argue, the fears should not stop the research.
"I don't think I'm playing God," Mitalipov says. "We have intelligence to understand diseases, eliminate suffering. And that's what I think is the right thing to do."
More:
Scientists Try Gene Editing In Human Embryos : Shots - Health ... - NPR
Posted in DNA
Comments Off on Scientists Try Gene Editing In Human Embryos : Shots – Health … – NPR
Updating DNA’s Life Story – The New York Times – New York Times
Posted: at 5:50 pm
Photo Credit Joon Mo Kang
It is incredible enough that anyone ever discovered the structure of DNA. (James D. Watson, Francis Crick and Maurice Wilkins were awarded the Nobel Prize in 1962 for their research on the subject.) But the progress that has since been made in sequencing and editing our genetic building blocks is perhaps even more dizzying.
An updated edition of Watsons book DNA: The Story of the Genetic Revolution, first published in 2003, includes a new chapter on the progress in cancer research and another on the latest science in (and implications of) personal genomics. In 2007, Watson was one of the first people to have his own genome completely sequenced. He estimates that about 400,000 others have now been done.
Watson, 89, retired as chancellor of the Cold Spring Harbor Laboratory on Long Island in 2007 after an uproar that followed offensive remarks he made generalizing about the intelligence of people of African descent. Not often in the public eye since then, he uses the opportunity of the new version of DNA to opine on developments in the field.
Watson writes in one new part of the book: I for one wholeheartedly endorse consumers right to know their personal genetic information and to take what measures seem appropriate. But when he had his own DNA mapped, there was one thing even he didnt want to know: whether he had the gene associated with a heightened risk of Alzheimers disease. I had absolutely no desire, he writes, to waste time worrying about having some genetic predisposition to such a hideous disease.
Quotable
I do not think novels are necessarily more worthwhile than games. A novel can be a trivial waste of time, and a game can teach. . . . At their best, novels and games serve as vehicles for discovery. Allegra Goodman, in an interview with Commonweal
Tall Waves and Deep Thoughts
James Ryerson reviews Aaron Jamess Surfing With Sartre this week. Something about chasing a good wave does seem to lend itself to deep thoughts. Jaimal Yogiss new memoir, All Our Waves Are Water, seeks profound spiritual lessons in the ocean. In addition to earnestly New Age-y moments, like ruminating on the scientific similarity between amniotic fluid and saltwater, Yogiss approach makes room for self-deprecation. Its also not just about him; Yogiss previous memoir, Saltwater Buddha, detailed his running away from home to surf and join a monastery as a teenager. Much of this new book revolves around his friendship with a displaced Tibetan named Sonam, and so, Yogis writes, surfing and Zen are just big characters among many.
A version of this article appears in print on August 20, 2017, on Page BR4 of the Sunday Book Review.
See original here:
Updating DNA's Life Story - The New York Times - New York Times
Posted in DNA
Comments Off on Updating DNA’s Life Story – The New York Times – New York Times
I sent in my DNA for a personalized nutritional blueprint. Here’s what … – Washington Post
Posted: at 5:50 pm
By Sophie Egan By Sophie Egan August 18
Today is National Ice Cream Pie Day. (Its also the third week of National Crayon Collection Month, but whos counting?) You know whose arteries ice cream pie is good for? No one. Plain and simple. But Habit, one of the latest disrupters in the food tech sector, suggests we rethink the very notion of foods that are good for everyone or bad for everyone. Its part of a movement toward what is called personalized nutrition.
Habit, based in the San Francisco Bay area, tests for biomarkers and genetic variants using samples you provide, then generates a personalized report about how your body responds to food. Its your unique nutrition blueprint. Then the company pairs you with a nutrition coach and offers you custom-made meals, containing your ideal ratio of carbs, fats and protein, delivered to your home. All in the name of sending you on the path to a new you.
[Breakfast was the most important meal of the day until America ruined it]
I had to see for myself. So I endured the home test and shipped off my blood and DNA samples. (Gulp.) Then the companys chief executive walked me through the results of my newfound eater identity, and I observed how the diagnosis began to affect my relationship with food. Heres what happened and what it could mean for the future of eating in America.
Digesting the news
The Habit home kit is not for the faint of heart. After fasting for 10 hours, you answer lots of deeply personal questions, scrub DNA samples from your cheeks and puncture your fingertips with a self-pricking button (technical term: lancet). This sounds rough, but my lowest moment is actually chugging their special Habit Challenge Shake. It clocks in at 950 calories, 75 grams of sugar and 130 percent of daily saturated fat intake. It has a taste and smell I can only liken to Kahla. It makes me feel god-awful while drinking it nose pinched, pinkie out, face scrunched and even worse afterward. It was bad enough I had sacrificed my Saturday morning frittata ritual.
By the third blood sample, my dining table looks like a crime scene. Ive got bandages on two fingers, mini disinfectant pads strewn around, and cherry red blood dripping down my forearm. Im angling my elbow like a helicopter hovering over the little blood collection card, just trying to fill the darn box one last time so I can move on with my day. Finally, I pack it up and mail it all off in a rather alarming biohazard bag. The whole ordeal takes about three hours and costs $309.
[No food is healthy. Not even kale.]
Im told Ill receive my results in a few weeks. While I wait, I wander back to the Habit website and take a closer look at those pages and pages of fine print. I start to have second thoughts at sentences like, You may experience stress, anxiety, or emotional or physical discomfort when you learn about health problems or potential health problems.
Then theres this: Recommendations regarding diet provided to you may or may not be beneficial to you and may cause or exacerbate certain medical problems.
Say what?
Thankfully, when the results come in, I get labeled a Range Seeker. In official Habit-speak, it means you can be flexible with your macronutrient intake and thrive on a range of foods. Well, thats a relief.
[Heres how much giving up beef helps or doesnt help the planet]
There are seven Habit types, each with dozens of more specific sub-variations, varying from Slow Seeker (best suited for foods rich in fiber and carbs that are absorbed slowly) to Fat Seeker (fat is a valuable fuel source for you). Along with receiving your tribal designation, youre assigned a personalized eating plan, depicting your ideal plate, suggested nutrient goals and daily calorie target.
Id be lying if I said the results havent been affecting my food choices, or at least the way I feel about my food choices. For instance, since being told I have a genetic risk variant associated with slow production of omega-3s, I have been seeking salmon like a grizzly bear. Apparently, Im also genetically predisposed to caffeine sensitivity. Many a morning, this news has me sitting at my desk thinking I must be tripping out on my cup of joe despite the fact that I have consumed the exact same amount of coffee every day of my adult life.
Conviviality, an endangered species
On the face of it, personalized nutrition makes sense. Why wouldnt I want to understand the unique dietary yearnings and land mines of my own DNA? Many people seem to feel that the existing national dietary guidance of one-size-fits-all has failed them. Theyre sick, and theyre confused about what to buy and what to order.
But in reducing food to individualized nutrient optimization equating food with fuel, really what are we sacrificing? What are the implications for our food culture and the future of dining? Oh, gosh, Id love to go out for sushi with you, but I have to scurry home to my prearranged Range Seeker box in the fridge.
[Why your humble bowl of oatmeal could help feed a growing planet]
Neil Grimmer, Habits founder and chief executive, recognizes that food is social. He tells me that it knots us together culturally, so Habit is in the process of facilitating online communities for people with the same Habit type. Through a private Facebook page, they could share tips and the like. Its better than going it alone, I guess, but a far cry from actually sharing a meal.
Remember the $300 you put down for the home test? It includes a coaching session, so a nutritionist helps you put all your information into practice. During my session, Jae Berman, a registered dietitian, nutritionist and head coach of Habit, is a great help. But things dont look so rosy when I ask her how Im supposed to integrate Habit into regular life.
The family conversation has been one of the most common questions we have gotten, she says. It doesnt occur to me as a problem because I just want people to take ownership of their story ... have the empowerment to say, This is what my plate looks like; thats what your plate needs to look like, and move on. Even, she says, if that means everyone at the table eating something different. Have you ever tried being the short-order cook in that scenario? It all but requires outsourcing the meal making.
Imagine, Berman says, a mom whos stressed out, with kids running around, a husband who is a rail, all the while she has no time for herself, is struggling with her weight, and trying to figure out what on earth to cook for dinner. Most people dont want to talk about uncomfortable things, Berman says. But let your kids eat mac and cheese, let your husband do what he needs, and let you have this plate for your dinner. You dont need to do anything its going to show up at your door.
This desire to customize our food experiences stems from the uniquely American trait of individualism. Often subconscious, its a desire to be exceptional, distinct from those around us, as opposed to being part of a larger collective. By contrast, many other cultures around the world are characterized by interdependence. It turns out, individualism shapes our eating habits in stunning ways, from the rise of solo dining to customization as a firmly expected attribute of eating out.
Habit is the latest example of a new technology enabling that innate premium on personalization, and over time, these tools are pulling us further and further from the table. Think smartphones making us feel less alone while eating alone, and mobile ordering apps allowing us to tailor our meal delivery times and our restaurant orders with greater precision. With roughly half of all eating occasions now taking place when were by ourselves, were getting less and less practiced at eating with others.
This reality has major implications for our food culture, and for the rising rates of social isolation in the United States. You know what the single greatest predictor of happiness is? Social connectedness. And guess what: Its one of the greatest predictors of longevity, too.
Of course I want people to eat food thats right for them. But we also have to ask ourselves: Which is really going to make us live longer, and live better? The ability to pay more granular attention to our triglyceride levels, or the more holistic benefits of eating with family and friends?
My grandmother turned 100 this year. Between the birthday parties and the bridge club, her standing dinner dates and the three times a day she picks up her neighbors in their retirement home hallway to take their walkers down to the dining hall, a thriving social life is Almas secret to a long life. Whether Im chomping on my salad, face glued to my iPhone, or waving off her breakfast offer by citing the low-glycemic Kind bar I just finished off, she tells me time after time: Shed take the cake and the friendships any day.
Egan is author of Devoured: How What We Eat Defines Who We Are (William Morrow/HarperCollins), recently released in paperback.
Originally posted here:
I sent in my DNA for a personalized nutritional blueprint. Here's what ... - Washington Post
Posted in DNA
Comments Off on I sent in my DNA for a personalized nutritional blueprint. Here’s what … – Washington Post
Wamberg Genomic Advisors Launched to Provide Easy Access to Affordable Genomic Testing – Markets Insider
Posted: at 5:50 pm
LA JOLLA, Calif., Aug. 20, 2017 /PRNewswire/ -- Tom Wamberg, one of the nation's foremost experts on employee benefits and insurance, today announced the formation of Wamberg Genomic Advisors (WGA). WGA advises employers, employee benefit brokers, and life insurance companies, enabling them to create programs that provide employees and policyholders with easy access to affordable genomic tests.
Genomics is the study of the structure and function of genomes, including all of an individual's genes. In contrast, genetics focuses on the variation and function of single or limited numbers of genes within a genome. In the context of human health, genomics seeks to identify the interrelation of factors beyond genes, which can lead to a deeper understanding of the risk of disease, resulting in more effective preventive measures or treatments. Genetics looks for specific mutations or variations within genes, rather than the entire genome. While genetics provides important information in understanding a person's health status or risk for certain diseases or conditions, the information that can be learned from examining an entire genome is broader.
"Knowledge of a person's genome is enabling medical professionals to develop personalized health strategies, treatments, and care paths that can be used to better manage or prevent disease and enhance health and longevity," said Wamberg. "When patients are empowered with this knowledge, they can become more actively engaged in managing their own health and make better decisions. As more people have their genome sequenced and analyzed, the medical and health care communities are better equipped to provide deeper insights into risk and disease, and make new medical discoveries.
"Our mission is to help drive the genomic revolution by making genomic testing readily accessible and affordable for everyone," added Wamberg. "The most promising avenues for widespread delivery of genomic testing are employee benefit programs and life insurance policies."
For more than three decades, Wamberg has developed innovative benefit and financial strategies for employers of all sizes, from emerging growth companies to the Fortune 100, as well as life insurance companies. Before starting WGA, Wamberg was chairman and CEO of Clark Consulting, a leader in the executive benefits space. In addition to serving as CEO of WGA, Wamberg is chairman of Uniphy Health LLC, which he co-founded, and a member of the Board of Trustees of Cleveland Clinic.
WGA will focus initially on the following types of genomic products and services:
Whole genome sequencing and reporting. The most comprehensive method for analyzing the genome
Exome sequencing and reporting. Information on all the genes that express proteins in a genome
Cancer genomic profiling. Sequencing of a cancer tumor to learn about coding mutations that contribute to tumor progression
Cancer liquid biopsy. Blood test that today can be used in limited circumstances to detect cancer genomic material circulating in the blood, such as when sufficient tumor material is unavailable
Lifetime stem cell banking. Stem cells gathered at birth to serve as a source of cellular material for the treatment of conditions throughout a person's life
Lifetime connectivity to one's DNA. Information and updates on variations in a person's genome when compared against constantly updated genomic databases
About Wamberg Genomic Advisors
Wamberg Genomic Advisors (WGA) is your partner in the Genomic Revolution. Our mission to make genomic testing readily available at prices everyone can afford. Our focus is on delivering genomic products and services to employers and their employees via their trusted benefit brokers, and policyholders of life insurance companies. To discover more about WGA and the future of genomics, visitwamberggenomic.com.
View original content with multimedia:http://www.prnewswire.com/news-releases/wamberg-genomic-advisors-launched-to-provide-easy-access-to-affordable-genomic-testing-300506867.html
SOURCE Wamberg Genomic Advisors
Posted in Genome
Comments Off on Wamberg Genomic Advisors Launched to Provide Easy Access to Affordable Genomic Testing – Markets Insider
Doctor: Eczema medications for children could have long-term side effects – WTSP 10 News
Posted: at 5:49 pm
A doctor says children using the skin medication for eczema may have problems later.
Shannon Valladolid, WTSP 11:36 PM. EDT August 19, 2017
Eczema causes the skin to become inflamed.
Kids can have a lot to deal with. School, sports, bullies, the list goes on.
But imagine also dealing with this as well: severe eczema.
Five-year-old Allison and 11-year-old Imaan may be different ages, but they have one thing in common.
I have eczema and I can only eat and wear certain things, says Imaan.
One time my friend told me she didn't like the look of my eczema on me, says Allison.
This is what their eczema looked like before getting on medication.
The girls suffer from eczema.
Both girls said they felt excruciating pain.
I got hospitalized twice. Even when I took a shower, every time water went on me it hurt and there was cuts everywhere, says Imaan.
Dr. Seth Forman with Forward Clinical Trials has been treating the girls for their skin condition.
But while they're breathing a sigh of relief now, Forman says these strong medications they're on could have long term side effects.
The medications that are available right now can cause kidney dysfunction, liver toxicity and other effects to the immune system, says Dr. Forman.
Forman conducts many clinical trials on a wide array of skin conditions like rosacea and psoriasis. He's been pushing to change current regulations that limit young children from being a part of these trials.
We need these newer medications to be approved by the FDA and we need more companies to do research with children, he says. So, we can avoid using these medications.
Right now, those newer medications can be used on adults but not children.
So, in the meantime, girls like Allison and Imaan might have to pay the price in the future for clear skin.
RELATED: Local clinical trials may offer more options for psoriasis patients
Makeit easy to keep up-to-date with more stories like this.Download the 10 Newsapp now.
Have a news tip? Email tips@wtsp.com, visit ourFacebook pageorTwitter feed.
2017 WTSP-TV
Original post:
Doctor: Eczema medications for children could have long-term side effects - WTSP 10 News
Posted in Eczema
Comments Off on Doctor: Eczema medications for children could have long-term side effects – WTSP 10 News
This Stock Could Be the Tesla of Healthcare – Madison.com
Posted: at 5:48 pm
Some farsighted (or just plain lucky) investors bought shares of Tesla Motors (NASDAQ: TSLA) early on. They took a huge risk, but that risk paid off. Tesla stock is up nearly 1,400% since the company went public in 2010.
Stocks like Tesla are a pretty rare species. And they're not always easy to spot early on. But some are still out there. One stock that is in its infancy right now that could be a huge winner in the next few years is gene-editing pioneerEditas Medicine (NASDAQ: EDIT). Could Editas be the Tesla of healthcare?
Image source: Getty Images.
Tesla wasn't the first automaker to create an electric car. The first electric car in the U.S. dates back to 1890. However, Tesla did introduce a new-and-improved version of the electric car that captured the attention of consumers.
Likewise, Editas isn't the first biotech to use gene editing -- the insertion, deletion, or replacement of DNA in a cell or organism. Others have been working on developing drugs using gene-editing techniques for a long time before Editas was formed. Sangamo Therapeutics (NASDAQ: SGMO), for example, got its start in 1995 and has been researching potential applications of gene-editing therapies ever since.
But like Tesla, Editas has a new-and-improved approach to an idea that's been around awhile. Sangamo uses a gene-editing method called zinc finger nuclease (ZFN) technology. ZFN was introduced in the early 1990s. Editas uses the CRISPR-Cas9 gene editing approach, which wasn't discovered until around five years ago.
CRISPR-Cas9 has several advantages over older gene-editing technologies. As was the case with Tesla's cars compared to previous electric cars, CRISPR-Cas9 is better and faster than the alternative methods for editing genes. It's easier to build, and it can modify DNA with greater precision. And CRISPR-Cas9 is cheaper as well (something Tesla hasn't been able to claim until recently).
Some think only of electric cars when they think about Tesla. The reality, though, is that Tesla's vision is much bigger than electric cars: Its plan is to promote sustainable energy sources in all areas of life.
It's also possible to look at Editas in a narrow way. The biotech's pipeline currently includes seven pre-clinical programs. One of those programs is a collaboration with Juno Therapeutics (NASDAQ: JUNO) to use gene editing in engineering T cells to fight cancer. Editas' lead program EDIT-101 targets treatment of rare genetic eye disease Leber Congenital Amaurosis type 10. The company plans to submit an Investigational New Drug (IND) application for EDIT-101 next year.
Image source: Getty Images.
There's a much bigger potential for Editas than just those few programs, though. The company has licensed exclusive rights to patents for the use of CRISPR-Cas9 in editing eukaryotic cells (i.e., any cells with a nucleus, including all human and animal cells). Editas also licensed patents to another type of gene editing, CRISPR-Cpf1, that could be even better than CRISPR-Cas9 for some mutations.
What does this mean for Editas' potential? There are around 6,000 diseases caused by genetic mutations. Over 95% of them don't have an approved therapeutic alternative. Even where there are approved therapies, they often only treat the symptoms of the disease. CRISPR-Cas9 and CRISPR-Cpf1 hold the potential to be used to treat many of these genetic diseases, particularly those affecting bone marrow, eyes, liver, lung, and muscle. Editas will be a go-to partner for many biopharmaceutical companies wanting to target those diseases.
Allergan (NYSE: AGN) became the first big pharma company to join forces with Editas earlier this year. The two companies are working together to develop gene-editing drugs for several eye disorders. This deal also allows Allergan to license Editas' lead program, EDIT-101.
It's not an exaggeration to speculate that Editas Medicine's potential could be greater than Tesla's if Editas' gene-editing technology helps cure a range of serious diseases. However, at this point, it would be only speculation. None of Editas' programs have even reached clinical trials yet. The odds of any program making it all the way to approval are low -- less than 10% based on the Food and Drug Administration's analysis of all experimental drugs.
There's also the possibility that even better gene-editing techniques will be discovered. That wouldn't derail Editas' efforts -- after all, Sangamo continues to move forward with ZFN even though the technology has been eclipsed by CRISPR. However, a gene-editing approach that proved to be better than CRISPR would probably drastically reduce the appeal of Editas as a partner for larger companies wanting to develop treatments for genetic diseases.
Editas could truly be the Tesla of healthcare. For now, though, the key word in that statement -- "could" -- is future tense.
10 stocks we like better than Editas Medicine
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Editas Medicine wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of August 1, 2017
Keith Speights has no position in any stocks mentioned. The Motley Fool owns shares of and recommends Tesla. The Motley Fool recommends Juno Therapeutics. The Motley Fool has a disclosure policy.
Originally posted here:
This Stock Could Be the Tesla of Healthcare - Madison.com
Posted in Gene Medicine
Comments Off on This Stock Could Be the Tesla of Healthcare – Madison.com
Genome Cloaking Preserves Privacy While Enabling Diagnosis … – PLoS Blogs (blog)
Posted: at 5:48 pm
Sequencing genomes to diagnose puzzling symptoms presents a conundrum: how to interpret whether a persons genotype causes the syndrome without comparison to many other human genome sequences? Put another way, a gene variant (mutation) that people with the same symptoms share must also be absent in people without the syndrome for it to be labeled causal, rather than the disturbingly vague variant of uncertain significance.
The challenge is in de-identifying the hordes of healthy genomes needed to add diagnostic context to those with disease-causing mutations. A team of biologists, computer scientists, and cryptographers at Stanford University described in Sciencemagazine a new computational tool to make certain that genomic discrimination doesnt happen, according to co-author Gill Bejerano, PhD, associate professor of developmental biology, pediatrics, and computer science.
A genome sequence can reveal much more than the needle-in-the-haystack mutations that might underlie a diagnosis: parentage, ancestry, susceptibilities and risk factors, even whether a certain drug will work, binge-drinking make you violently ill, or smoking likely to cause lung cancer. How can genome sequencing provide useful information without sacrificing privacy?
THE CLASSIC GYMREK STUDY
One of my favorite papers is also from Science, Identifying Personal Genomes by Surname Inference,if you can call a report from 2013 a classic. First author was then-grad student Melissa Gymrek, who now heads a lab at UCSD.
Gymrek and her co-workers tackled the 1000 Genomes Project, which ran from 2008-2015 and spawned a supposedly anonymous database. The informed consent form read, . . . it will be hard for anyone to find out anything about you personally from any of this research.
Right. Online searches easily shattered that premature promise of privacy.
Gymrek, then a student of Yaniv Erlich, a researcher at the Whitehead Institute who had worked with databases at financial banks, tried to identify people whod anonymously donated DNA to the 1000 Genomes Projectjust to see if they could.
They looked at sets of short tandem repeats, the bits of sequence of 2-13 DNA bases used in forensics and genetic genealogy to distinguish individuals. Consulting public genealogy databases they found surnames corresponding to specific Y haplotypes (STRs linked on the male chromosome).
Basic public information such as state of residence and birth year was easy to find. DNA data posted on family websites confirmed some identifications. The researchers found women by cross-referencing DNA sequences in the Coriell Cell Repositories in New Jersey to other data. Searching mutation databases for disease, hometown, and date of birth identified children.
When Gymrek had identified 50 people fairly easily, Dr. Erlich, alarmed, notified the NIH, catalyzing efforts to begin to hide some of the DNA data, although of course they couldnt control people whod post anything on social media. Their report in Science became a rallying cry of sorts for the ease of assigning names to DNA sequences something thats much easier today, with more than a million of our genomes sequenced and with the ability to carry such information on our smartphones.
THREE COMPELLING EXAMPLES
In the new paper, the researchers used a cryptographic approach called Yaos protocol with cloud computing to enable a genome peruser to zero in on the DNA sequences of clinical interest, while ignoring all else. Its a genomic cloaking device, for those familiar with the Romulan invention from Star Trek that makes a spaceship seem to vanish. It irked Captain Kirk.
Aterrific news releaseby Krista Conger at Stanford explained it all:
Using the technique, the researchers were able to identify the responsible gene mutations in groups of patients with four rare diseases; pinpoint the likely culprit of a genetic disease in a baby by comparing his DNA with that of his parents; and determine which out of hundreds of patients at two individual medical centers with similar symptoms also shared gene mutations. They did this all while keeping 97 percent or more of the participants unique genetic information completely hidden from anyone other than the individuals themselves, the release said.
Many news aggregators just publish news releases verbatim, but I dug a little deeper:
For the four already-known diseases, the technique identified 211-374 rare functional gene variants in 210- 356 genes (meaning more than one mutation in some genes) among the patients, then selected the most likely candidates. The computation correctly identified the mutation in all four across all 20,663 genes, and in 5 to 10 seconds. Anyone who reads this blog regularly knows that a diagnostic odysseyfor a rare genetic disease can take years, using conventional medicine.
The baby was XY (chromosomally male) with female genitalia. The child and the parents each had 164-185 rare functional variants found with exome sequencing, and the computation revealed only two unique to the child. A review of the genetics literature found that one, ACTB, made sense and it had been found in the 1000 Genomes Project! Only the two meaningful variants were reported to the parents and their provider, leaving what the researchers call a protection quotient of 99.6%. (Definition: the fraction of private information that is exposed neither to the other participants nor to the entity running the computation.)This more complex test took just under an hour.
The researchers compared 928 patients from one medical center to 282 patients at another, generating a list of 5,000+ rare functional variants seen in at least one patient, then whittled it down to 159 variants seen among patients in both hospitals. The info diagnosed patients with specific heart problems, and also revealed previously unrecognized gene-disease connections so the computation is a discovery tool too.
BENEFITS TO GENOME CLOAKING
The beauty of the technique, and the secret to the privacy promise, is that the patient enters the data, into smartphone, tablet, or computer. That shouldnt sound scary, for we send our info into the ether all the time, from ordering concert tickets to making plane reservations. In this way, no person or computer, other than the individuals themselves, has access to the complete set of genetic information, said Dr. Bejerano.
The computation encrypts a genome sequence into a linear series of values that rates each gene variant according to several criteria well-established among genome researchers:
Could the genes function explain a patients symptoms?
Is the variant rare? This is where the need for a backup million or so sequenced genomes comes in. If a variant is common, it cant be making people too sick to reproduce.
Is the variant functional? What does it do?
The direct involvement of the patient and the return of only relevant data from the cloud can avoid the genetic red flags that might underlie denial of a loan or life insurance, neither protected under the Genetic Information Nondiscrimination Act (GINA), should it survive the Trump administration. And the data from the healthy genomes is aggregated without identifiers.
Genome cloaking at some point requires interpretation of and communication by health care providers who are familiar and comfortable with DNA information. That might still be a rare breed. Heres a quick test that I just invented for a provider discussing genetic testing: define SNP, CNV, VUS, and exome. If she or he cant, find a genetic counselorpronto. The medias common depiction of physicians as scientists the Dana Scully effect, from the X-Files doctor constantly calling herself a scientist can set up unrealistic expectations of expertise.
Another advance that could come from genome cloaking would be, finally, the ability to track sets of genes. This is important because gene actions can oppose. Whats the use of finding out you have a gene variant that increases the risk of Alzheimers, like APOE e4, yet not knowing that you also inherited a gene variant that lowers the risk (APOE e2)?
With the ability to nail disease-causing gene variants, while offering the privacy that Melissa Gymreck showed years ago to be easily compromised, genome cloaking may be able to catapult DNA science into the research lab and clinic, by providing reassurance to both families with genetic disease and to the healthy population whose genome sequences are vital to providing context.
(Thanks to NHGRI for images.)
Read the original here:
Genome Cloaking Preserves Privacy While Enabling Diagnosis ... - PLoS Blogs (blog)
Posted in Gene Medicine
Comments Off on Genome Cloaking Preserves Privacy While Enabling Diagnosis … – PLoS Blogs (blog)
I want the Raiders to be boring in 2017 – Fairfield Daily Republic
Posted: at 5:48 pm
My brother Kelvin recently said that going to see a preseason NFL football game is like going to see your favorite band audition new members.
That was definitely what the Raiders- Rams game on Saturday night felt likeespecially the second half.
It was heartening to see quarterback Derek Carr slinging it to Michael Crabtree or Cooooooooop or better yet handing it off to Beast Mode for the first time.
Defense though? Oi.
Khalil Mack had a monster sack on Rams quarterback Jared Goff, which was just about the sole Raiders defensive highlight of the entire game.
The Rams were hardly a powerhouse in 2016 and their anemic 4-12 record resulted in their head coach Jeff Fisher getting a cleated boot to the backside. So thats why it was startling how many times Saturday night Raider defenders were so far out of position that their only hope of stopping wide open Rams receivers from catching passes would be to fling their helmets at them.
Look, the Raiders offense is potent, I get that. What matters in the NFL is having at least one more point than the other team when the clock reads all zeroes at the end of the game (and Im still hoping to see one won by a 2-0 score some day by the way). Having the reigning Comeback Kid as QB is a wonderful asset, but defense winsyou know the rest.
Last year at this time, my hope/expectation for the team was that they finally have a winning season. They won 12 games and got a playoff berth. This year, I want them to win the AFC West.
That means beating a certain Midwest divisional foe with a politically incorrect name who wear garish ketchup and mustard colored costumes. Not looking past Denver or San Dieger, Los Angeles, but it has been a while since Ive enjoyed Chiefs fans forced silence.
I loved the grit displayed last season when Carr led so many thrilling late-game comebacks, but this season, at home games, I want to weed out any bandwagon fans. Some come for the excitement of game-on-the-line heroicsI want them to be bored.
I want the Raiders to be consistently dominant so that that by the third quarter of each game the lead is so insurmountable that only diehards like yours truly will want to stay and savor every single last second.
In short, I want to regularly see visiting teams get a smackdown/beatdown when they come to downtown Oaktown.
Fairfield Raider fanalistpart fan, part journalistTony Wade knows it is only preseason. Reach him at toekneeweighed@gmail.com
View post:
I want the Raiders to be boring in 2017 - Fairfield Daily Republic
Posted in Politically Incorrect
Comments Off on I want the Raiders to be boring in 2017 – Fairfield Daily Republic